OUTLOOK FOR BIOPHARMACEUTICALS: THOMAS DIETZ – PACIFIC GROWTH EQUITIES LLC
THOMAS J. DIETZ is Senior Managing Director for Pacific Growth Equities,
LLC. He joined the firm in 1993 as the Senior
Biotechnology/Biopharmaceutical Analyst and currently serves as the
Senior Managing Director in Research. His is a leading voice on Wall
Street for biotechnology stocks. Prior to joining Pacific Growth, Dr.
Dietz was a research faculty member at U.C. San Francisco. His research
has been funded by the National Institutes of Health, the National
Science Foundation and by NASA. Dr. Dietz earned a BS degree from the
State University of New York, Albany, a PhD degree in Molecular Biology
and Biochemistry from Washington University, and was awarded a
postdoctoral fellow from the National Science Foundation. Profile
TWST: What is the focus of your coverage at Pacific Growth Equities?
Dr. Dietz: The biotechnology/biopharmaceutical team covers all of the